Production of isoprenoid pharmaceuticals by engineered microbes. - Wikidata - awgldk - TriplyDB

Production of isoprenoid pharmaceuticals by engineered microbes.

Production of isoprenoid pharmaceuticals by engineered microbes.

http://www.wikidata.org/entity/Q46052551

about

Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli Versatile biocatalysis of fungal cytochrome P450 monooxygenases Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids Rapid Discovery and Functional Characterization of Terpene Synthases from Four Endophytic Xylariaceae Development of bio-based fine chemical production through synthetic bioengineering Engineering microbial factories for synthesis of value-added products Progress in metabolic engineering of Saccharomyces cerevisiae Enzymatic process optimization for the in vitro production of isoprene from mevalonate Utilization of alkaline phosphatase PhoA in the bioproduction of geraniol by metabolically engineered Escherichia coli Engineering Escherichia coli to convert acetic acid to β-caryophyllene Metabolic engineering of Escherichia coli for the biosynthesis of alpha-pinene Effect of land-use change and management on biogenic volatile organic compound emissions--selecting climate-smart cultivars.Spirotetronate polyketides as leads in drug discovery.Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid.The challenges of informatics in synthetic biology: from biomolecular networks to artificial organisms Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens.Diverse bacterial microcompartment organelles Toward biosynthetic design and implementation of Escherichia coli-derived paclitaxel and other heterologous polyisoprene compounds.Combined metabolic engineering of precursor and co-factor supply to increase α-santalene production by Saccharomyces cerevisiae Improving yeast strains using recyclable integration cassettes, for the production of plant terpenoids.Combinatorial engineering of mevalonate pathway for improved amorpha-4,11-diene production in budding yeast.The microbiome and cancer.Biosynthesis of Taxadiene in Saccharomyces cerevisiae : selection of geranylgeranyl diphosphate synthase directed by a computer-aided docking strategy Evolutionary Engineering Improves Tolerance for Replacement Jet Fuels in Saccharomyces cerevisiae Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli An expression tag toolbox for microbial production of membrane bound plant cytochromes P450.Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by Escherichia coli Controlled biosynthesis of odd-chain fuels and chemicals via engineered modular metabolic pathways.A synthetic Escherichia coli predator-prey ecosystem.Engineering Escherichia coli for high-yield geraniol production with biotransformation of geranyl acetate to geraniol under fed-batch culture.Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli.Microbial production of C13-norisoprenoids and other aroma compounds via carotenoid cleavage.Identification, characterization and molecular adaptation of class I redox systems for the production of hydroxylated diterpenoids Programming microbial population dynamics by engineered cell-cell communication.Recent advances in the discovery and development of marine microbial natural products.Beyond patchwork precaution in the dual-use governance of synthetic biology DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways.Design-driven, multi-use research agendas to enable applied synthetic biology for global health The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

P2860

Q24630359-CC94B83A-3F64-4285-961A-3D5FDAD0732D Q26739208-D7BC4786-FD6D-4FB5-A5EF-478AA5F17C71 Q26739981-E5768A9A-CC9E-4F3D-A6B9-1A4F00E8169C Q28604171-A71D3544-8B30-4F6A-8937-BE32A39964CC Q28651737-50883CD5-D947-4DF2-B597-C2976883CA84 Q28742251-788EE2A9-DC26-4582-AC64-02D7C4298F9C Q28757069-5FCDAB6D-3D22-4D2D-B8D4-4178DA791DF9 Q28817670-8C29307C-F1DE-4E6F-A940-0DA6940A5CB5 Q30383231-39E6CD7E-7439-4478-8549-A22D9F7BE114 Q30384778-2B0B9B7F-CB28-4593-84CB-C276DEF9BB1D Q30393697-ADA1A17E-9275-4805-B998-64CCEC870288 Q30855182-13CC243D-3F85-47CA-B1EF-43F1C7B81FA2 Q30872494-B3EB178A-089F-45A5-B79A-D505A88C261E Q33382538-67884AAF-EC32-4537-81F5-5960339C7684 Q33605059-9BB9C386-A66A-4706-8A21-C5B293C80570 Q33610129-EC36D5A9-40CE-491B-AAA3-2CC5F2E9D3F9 Q34041895-75C8AC55-D27C-4AF5-9143-9459F6ECCE6E Q34250480-73F5B2A0-1472-427F-80B3-698E8991A962 Q34296949-0346F9FF-DF50-4509-9CDD-D7713915B8F7 Q34589523-0D8A92B3-39DA-4C3A-B6DF-0CD05FD46E55 Q35016516-97C1420A-1543-40E1-9ED8-11F607D7EE53 Q35019302-878F59D5-CC29-4A5B-84F5-E02ABC5E9547 Q35312072-3BF79F7D-ADC8-4CD6-BFC5-0BC24D893BFE Q35529883-904D8BE2-411C-4CF6-A3DE-7EC59A60DC3A Q35784729-749FF2AB-32BC-4B3D-AC2D-ED7F1D6E40B2 Q35913117-648C20EF-1347-40FA-AA3B-523239EFE821 Q36164921-B4404CD3-8EAE-43CE-8C36-ED86C2104401 Q36313677-69FE0F47-F79A-428E-991F-388694B81DFB Q36397718-24060772-9FC8-4414-8905-0E88EBF53253 Q36663520-67732F2F-153E-43BA-B5E0-9C69C0891FCC Q36675574-B4792386-09BC-48B3-B701-90CC7D4EC5DE Q36742753-EC41B3A3-7D9A-41D9-BDF4-44928B1D26E8 Q36892359-96D077D1-7876-4381-9739-47C6F67DC21D Q36929166-3EE7925C-CD45-49E8-B5D4-1F4BF0A47420 Q36969039-264AF1E5-A58D-4955-8A20-69A9CFEB2E1A Q36994135-2ADFB6B4-DF41-4569-A0FF-713AABAFEC8C Q37076560-9E21F402-6ABA-4810-8664-D68831D7E366 Q37077385-1FD819F1-0A3E-4CF0-B81D-C16FA5F54642 Q37086545-E40F2248-9155-401B-A92D-C391C2EE1F6D Q37107614-01B452A3-F3C3-4766-9CC4-54EED896FB39

P2860

Production of isoprenoid pharmaceuticals by engineered microbes.

http://www.wikidata.org/entity/Q46052551

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Production of isoprenoid pharmaceuticals by engineered microbes.

@en

Production of isoprenoid pharmaceuticals by engineered microbes.

@nl

type

label

Production of isoprenoid pharmaceuticals by engineered microbes.

@en

Production of isoprenoid pharmaceuticals by engineered microbes.

@nl

prefLabel

Production of isoprenoid pharmaceuticals by engineered microbes.

@en

Production of isoprenoid pharmaceuticals by engineered microbes.

@nl

P1433

Q46052551-741FA767-DDCC-43E1-9EDC-9F98127E1B47

P1476

Q46052551-A0C0836C-9789-413D-AC44-14DA5BDAB185

P2093

Q46052551-537BBC3D-0BB1-4BC4-A845-22963AB08C7C

Q46052551-CA294C85-38E1-4DEB-B7CC-4BB502D181AA

P2860

Q46052551-04BA569D-79CE-4AC6-A7AB-127D9E6FC52E

Q46052551-057EBD5F-594C-45A3-BB63-AFD229D50E03

Q46052551-06604D79-7CB7-41CA-B9A9-F3DCF5C60F87

Q46052551-084796F6-0131-435B-9AA1-B9DFDE89656B

Q46052551-0A2510C6-6F11-408D-90E7-013978DCDAD4

Q46052551-0D0B3A3E-DBDC-4DE0-B96B-8A01724EFA8E

Q46052551-0D8BD463-5CE3-4525-BFBD-6A588934DCA9

Q46052551-18D82AE8-B3A0-42C3-824C-663465DAFD9D

Q46052551-19110AD5-5970-4811-84C4-0C43C8E914A8

Q46052551-19BD62CD-F03A-4836-804E-D5E64940CEEB

P2888

Q46052551-970C1DA6-718A-4883-9AEE-EEE12EB67B6F

P304

Q46052551-E249679B-AC3D-40A8-B031-37B26C3E1EB7

P31

Q46052551-3CA78E61-65BD-41EC-AF8F-AAAC5D14ACFF

P356

Q46052551-D61843FF-10E4-470E-9F64-94F8703462C7

P433

Q46052551-61DB6568-82C7-4D81-B655-317AD36BFAF5

P478

Q46052551-0EA0C66B-8A1E-4A8E-8FCD-F31C14B24E61

P577

Q46052551-07615768-EDA4-445E-8519-FDAE664B1C85

P5875

Q46052551-326B2F42-4A2E-42FB-995E-2EFC48457117

P698

Q46052551-F21418C7-BA15-4334-8C0E-7067F784292C

P356

P1433

Nature Chemical Biology

P1476

Production of isoprenoid pharmaceuticals by engineered microbes.

@en

P2093

Jay D Keasling

http://www.w3.org/2001/XMLSchema#string

Michelle C Y Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Taxol biosynthesis: taxane 13 alpha-hydroxylase is a cytochrome P450-dependent monooxygenase

Taxol biosynthesis: molecular cloning of a benzoyl-CoA:taxane 2alpha-O-benzoyltransferase cDNA from taxus and functional expression in Escherichia coli

Molecular cloning of a 10-deacetylbaccatin III-10-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli

Molecular cloning, expression, and characterization of amorpha-4,11-diene synthase, a key enzyme of artemisinin biosynthesis in Artemisia annua L

Amorpha-4,11-diene synthase of Artemisia annua: cDNA isolation and bacterial expression of a terpene synthase involved in artemisinin biosynthesis

Engineering a mevalonate pathway in Escherichia coli for production of terpenoids

The in vivo synthesis of plant sesquiterpenes by Escherichia coli

The evolving role of natural products in drug discovery

Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast

P2888

P304

674-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCHEMBIO836

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6688823

http://www.w3.org/2001/XMLSchema#string

P698

17108985

http://www.w3.org/2001/XMLSchema#string